Semaglutide, the former, is still in the research phase
Ning LN, et al
Secondary, safety and negative control endpoints For individual components of the primary endpoint, semaglutide versus sitagliptin reduced myocardial infarction (HR 0.81, 95% CI 0.70 to 0.92) and stroke (HR 0.84, 95% CI 0.71 to 0.99) in the expanded populations at low, moderate and high cardiovascular risk
O., Simon, D
If your dose is in micrograms and youve only added a tiny amount of water, you may be forced to draw extremely small fractions of a milliliter, something thats hard to do precisely with a standard syringe
Heartburn on GLP-1: Why Reflux May Show Up Some patients notice heartburn, sour burps, belching, or a heavy food is sitting there feeling